A Study to Evaluate the Safety and Pharmacokinetics of XMAB24306 in Combination With Daratumumab in Participants With Relapsed/Refractory Multiple Myeloma
Cancer Multiple Myeloma
For the latest version of this information please go to www.forpatients.roche.com